Plus   Neg

Rent-A-Center Increases 2019 Guidance - Quick Facts

Rent-A-Center, Inc. (RCII) announced, for 2019, the company now expects non-GAAP earnings per share of $2.05 to $2.40, revised from prior guidance range of $1.85 to $2.25. Consolidated revenues are now forecasted in a range of $2.595 billion to $2.640 billion, updated from prior guidance range of $2.585 billion to $2.630 billion. Analysts polled by Thomson Reuters expect the company to report profit per share of $2.09 on revenue of $2.62 billion. Analysts' estimates typically exclude special items.

For the second-quarter, excluding special items, earnings per share were $0.60, compared to $0.47, previous year. On average, eight analysts polled by Thomson Reuters expected the company to report profit per share of $0.55, for the quarter.

Second-quarter consolidated total revenues were $655.9 million, flat year over year driven by a consolidated same store sales increase of 5.8 percent offset by refranchising over 100 locations since the first quarter of 2018 and closures of certain Core U.S. stores. Analysts expected revenue of $641.94 million, for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Video streaming giant Netflix said it will donate 1 million euros to Audiens, the social protection group of the French cultural sector, to help launch a COVID-19 emergency relief fund to support workers in the French television and cinema industry. Netflix and Audiens said they have created the new COVID-19 Film and TV Emergency Relief Fund to help the hardest hit workers in the industry. Major U.S. retail container ports are estimated to report a five-year low for imports in March as consumer demand has been impacted with millions of Americans out of work amid the coronavirus (COVID-19) outbreak, according to a report by the National Retail Federation or NRF. The U.S. Food and Drug Administration has issued warning letters to three sellers of fraudulent COVID-19 products. There are currently no approved preventatives or treatments for COVID-19, the FDA said in a statement.
Follow RTT